Search hospitals > California > Mountain View
Northern California Retina Vitreous Associates
Claim this profileMountain View, California 94040
Global Leader in Age-Related Macular Degeneration
Global Leader in Macular Degeneration
Conducts research for Diabetic Macular Edema
Conducts research for Diabetic Retinopathy
Conducts research for Retinal Degeneration
67 reported clinical trials
1 medical researcher
Summary
Northern California Retina Vitreous Associates is a medical facility located in Mountain View, California. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Retinal Degeneration and other specialties. Northern California Retina Vitreous Associates is involved with conducting 67 clinical trials across 36 conditions. There are 1 research doctors associated with this hospital, such as Mountain View Site PI.Area of expertise
1Age-Related Macular Degeneration
Global LeaderStage I
Stage II
CFI rare variant positive
2Macular Degeneration
Global LeaderStage I
Stage II
CFI rare variant positive
Top PIs
Clinical Trials running at Northern California Retina Vitreous Associates
Age-Related Macular Degeneration
Macular Degeneration
Diabetic Macular Edema
Choroidal Neovascularization
Choroidal neovascularization
Retinal Degeneration
Retinal Disease
None
Wet AMD
PDS Implant with Ranibizumab
for Age-Related Macular Degeneration
This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.
Recruiting2 awards Phase 33 criteria
4D-150 + EYLEA
for Age-Related Macular Degeneration
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
Recruiting2 awards Phase 34 criteria
RGX-314 Gene Therapy
for Wet Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. It aims to help the eye make its own medicine to stop harmful blood vessels from causing vision loss. This could reduce the need for regular injections. RGX-314 modifies the retina's cells to create a treatment that may only be needed once.
Recruiting1 award Phase 2 & 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Northern California Retina Vitreous Associates?
Northern California Retina Vitreous Associates is a medical facility located in Mountain View, California. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Diabetic Macular Edema, Diabetic Retinopathy, Retinal Degeneration and other specialties. Northern California Retina Vitreous Associates is involved with conducting 67 clinical trials across 36 conditions. There are 1 research doctors associated with this hospital, such as Mountain View Site PI.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.